Highlights Harbin Pharmaceutical Group Co., Ltd.

Equities

600664

CNE0000009T3

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
2.93 ^CNY	-1.68%		-5.18%	-12.54%

04-25	Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan	04-11	MT
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-10	CI
Roxatidine Hydrochloride for Injection of Harbin Pharma's Subsidiary Passes Drug Regulator's Evaluation	02-08	MT
Harbin Pharmaceutical Group's Cefotiam Hydrochloride Selected for China's Centralized Procurement Bid	11-08	MT
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	12/01/23	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	08/04/22	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/10/21	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	15/08/21	CI
Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement Product	17/05/21	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	02/04/21	CI
Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	29/10/20	CI
News Highlights : Top Company News of the Day	18/09/20	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Harbin Pharmaceutical Group Co., Ltd.

Equities

600664

CNE0000009T3

Highlights

Filters